numerous ova of S mekongi. The patient was treated with praziquantel 75 mg/kg daily taken in three divided doses three times with intervals of four hours. Four months later he still had some eggs of S mekongi in his rectal mucosa but many of them were black. He was treated again with praziquantel, and three months later there were no parasites in the rectal mucosa.
Introduction
Mycoplasma hominis is a common inhabitant of the genitourinary tract. 2 It has been associated with postpartum3 4 and postabortal fever,5 and some cases of pyelonephritis have been reported. 6 Its role as a pathogen in immunosuppressed patients has not, however, been established.
We report a case of severe immunosuppression in a patient in whom M hominis was isolated from several blood samples. The patient developed a high rise in antibody titre despite the severe immunosuppression.
A 38 year old man with a malignant lymphoma of lymphoblastic type in leukaemic phase was admitted to hospital with a temperature of 380C. As shown in the figure, treatment with r-lactam antibiotics was started on day 2, firstly with penicillin, then with a combination of methicillin and ampicillin, and later with cefotaxime. Despite treatment his temperature rose to 40°C. M hominis was isolated from blood cultures on days 4 , 5, and 6. The micro-organism was identified on Hayflick's agar medium7 by the disc growth inhibition test8 using a rabbit antiserum to M hominis strain PG21. Antineoplastic treatment was started on day 6 with prednisone 75 mg a day, vincristine 1 mg every week, and adriamycin 75 mg on days 7, 8, and 9.
The day after the start of corticosteroid treatment his temperature returned to normal and antibiotic treatment was stopped on day 10. On day 11 his temperature rose for a few hours to 39°C but no micro-organisms were isolated from the blood or urine. He was treated at home on days 14 and 15. On day 16 his temperature rose to 40 5°C and treatment with ampicillin, methicillin, and netilmicin was started. On day 17 the results of the blood culture were available and clindamnycin was added to the treatment regimen in a dose of 600 mg given intravenously four times a day. Over the next two days his temperature remained above 39°C and amphothericin B was given in addition. His temperature gradually returned to normal by day 25. Over this period the granulocyte count was increasing, having been less than 0-5 x 109/1 (500/mm3) since day 10 and less than 0-1 x 109/1 (100/mm3) from day 14 to day 21 
Discussion
The pathogenicity of M hominis in this case is indicated by the positive isolation from blood cultures on three different days, by the high rise in antibody titre, and by failure to grow other micro-organisms. The initial fall in temperature was probably caused by the corticosteroid treatment, but the high concentration of antibodies was probably responsible for clearing M hominis from the blood and for the patient being continuously afebrile until day 16. He did not receive any antibiotics active against M hominis until day 16. He had had a normal temperature since corticosteroid treatment began and had not received antibiotics since day 10 . The second episode of fever was presumably not caused by M hominis since he did not respond to the netilmicin or clindamycin. The presence of M hominis in the cultures can easily be overlooked since it grows more slowly than most bacteria, the colonies are pinpoint and translucent, and it fails to stain by Gram's method. No turbidity developed in the blood culture bottles.
Recovery of M hominis from the blood stream of men has been reported after manipulation or surgery of the urinary tract" 12 or after multiple trauma.'3 Only one study has reported isolation of M hominis from the blood in an immunosuppressed patient, but in this case no antibodies against M hominis were found in the blood.'4 Simberkoff and Toharsky reported that although fever and constitutional symptoms are often present, the finding of mycoplasmas in the blood is usually transient, lasting for less than a week even without effective treatment."1
The possible role of M hominis as a pathogen in immunosuppressed patients is not known, but this case indicates that this mycoplasma may cause septicaemia during immunosuppression. Infection with M hominis should be considered when an immunosuppressed patient has a fever of unknown origin.
